Igal Louria Hayon

Insider Reports History

Location
Tel Aviv Jaffa, Israel
Signature
/s/ Igal Louria Hayon
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Igal Louria Hayon:

Company Role Class Num Shares Value Price $ Report Date Ownership
Raphael Pharmaceutical Inc. Chief Technology Officer, Director Common Stock 999,000 $499,500 $0.5000 29 Aug 2023 Direct
Raphael Pharmaceutical Inc. Chief Technology Officer, Director Warrants to purchase Common Stock 0 29 Aug 2023 Direct

Insider Reports Filed by Igal Louria Hayon

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RAPH Raphael Pharmaceutical Inc. 29 Aug 2023 2 +$9,990 4 Chief Technology Officer, Director 25 Mar 2024, 16:01
RAPH Raphael Pharmaceutical Inc. 05 Dec 2022 1 $0 4 Chief Technology Officer, Director 13 Mar 2023, 16:02
RAPH Raphael Pharmaceutical Inc. 27 Sep 2021 0 $0 3 Chief Technology Officer, Director 19 Jan 2022, 10:02